Claims
- 1. An improved pharmaceutical composition for multi-symptom relief comprising the salt formed by the acid-base reaction of a non-steroidal anti-inflammatory drug selected from the group consisting of sulindac, ibuprofen, naproxen, dichlofenac and mixtures thereof and an antihistamine selected from the group consisting of diphenhydramine, ranitidine, loratidine, cimetidine, Hismanal, terfenidine and mixtures thereof on a 1:1 molar basis that is administered in a therapeutically effective single dosage form selected from the group consisting of capsules, tablets, elixirs, parenterals, suspensions and sachets.
- 2. An improved pharmaceutical composition for multi-symptom relief comprising an ion-pair formed by the acid-base reaction of a non-steroidal anti-inflammatory drug selected from the group consisting of sulidac, ibuprofen, naproxen, dichlofenac and mixtures thereof, and an antihistamine selected from the group consisting of diphenhydramine, ranitidine, loratidine, cimetidine, Hismanal, terfenidine and mixtures thereof, on approximately a 1:1 molar basis in a single, therapeutically effective dosage form selected from the group consisting of capsules, tablets, elixirs, parenterals, suspensions and sachets.
- 3. The pharmaceutical composition of claim 1 or 2 further comprising the addition of pharmaceutically acceptable excipients and non-toxic carrier materials.
Parent Case Info
This application is a continuation of U.S. patent application Ser. No. 07/664,018, filed on Mar. 4, 1991, now abandoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4783465 |
Sunshine et al. |
Nov 1988 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
664018 |
Mar 1991 |
|